Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 14, No. 5, 2015, pp. 837-843
Bioline Code: pr15110
Full paper language: English
Document type: Research Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 14, No. 5, 2015, pp. 837-843
© Copyright 2015 - Tropical Journal of Pharmaceutical Research
In vitro Synergy and Time-kill Assessment of Interaction between Kanamycin and Metronidazole against Resistant Bacteria|
Olajuyigbe, Olufunmiso O. & Afolayan, Anthony J.
Purpose: To evaluate the in vitro effects of combining kanamycin and metronidazole against resistant
Methods: The influence of combining kanamycin and metronidazole against Gram-positive and Gramnegative
bacteria was assessed by agar diffusion, checkerboard and time-kill assays.
Results: The test isolates were highly resistant, with minimum inhibitory concentration (MIC) ranging
between 15.63 and >250 μg/ml for kanamycin, and 15.63 and 125 μg/ml for metronidazole. The
antibacterial combinations resulted in drastic decrease in MIC with increased antibacterial activity that
indicated synergistic interaction against all the bacteria except Acinetobacter calcaoceuticus UP,
Enterobacter cloacae ATCC 13047 and Shigella flexneri KZN. Fractional inhibitory concentration index
(FICI) showed synergy ranging from 0.31 to 0.50, additive interaction with FICI ranging from 0.53 to
1.25 and absence of antagonistic interaction. Escherichia coli ATCC 25922, Enterococcus faecalis
ATCC 29212, Bacillus cereus ATCC 10702, Enterobacter cloacae ATCC 13047, Klebsiella pneumoniae
ATCC 10031, Acinetobacter calcoaceuticus UP and Micrococcus luteus were totally eliminated by the
antibacterial combinations within 24 h of incubation. The lack of antagonism between these antibacterial
agents in checkerboard and time-kill assays suggest that kanamycin may be effective in both
monotherapy and combination therapy.
Conclusion: The study indicates the potential beneficial value of combining kanamycin and
metronidazole in the treatment of microbial infections in clinical settings.
Drug-drug interactions; Synergy; Time-kill; Fractional inhibitory concentration index; Kanamycin; Metronidazole; Microbial resistance
Alternative site location: http://www.tjpr.org